nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfuzosin—CYP3A4—Calcitriol—psoriasis	0.0886	0.191	CbGbCtD
Alfuzosin—CYP3A4—Methoxsalen—psoriasis	0.0689	0.149	CbGbCtD
Alfuzosin—CYP3A4—Cholecalciferol—psoriasis	0.0456	0.0986	CbGbCtD
Alfuzosin—CYP3A4—Mycophenolate mofetil—psoriasis	0.0396	0.0855	CbGbCtD
Alfuzosin—CYP3A4—Triamcinolone—psoriasis	0.0396	0.0855	CbGbCtD
Alfuzosin—CYP3A4—Betamethasone—psoriasis	0.034	0.0733	CbGbCtD
Alfuzosin—CYP3A4—Prednisolone—psoriasis	0.0335	0.0724	CbGbCtD
Alfuzosin—CYP3A4—Hydrocortisone—psoriasis	0.0318	0.0686	CbGbCtD
Alfuzosin—CYP3A4—Prednisone—psoriasis	0.0316	0.0683	CbGbCtD
Alfuzosin—CYP3A4—Cyclosporine—psoriasis	0.03	0.0648	CbGbCtD
Alfuzosin—CYP3A4—Dexamethasone—psoriasis	0.0198	0.0427	CbGbCtD
Alfuzosin—Asthenia—Mycophenolic acid—psoriasis	0.000476	0.000886	CcSEcCtD
Alfuzosin—Infection—Hydrocortisone—psoriasis	0.000474	0.000882	CcSEcCtD
Alfuzosin—Dyspepsia—Cyclosporine—psoriasis	0.000472	0.000879	CcSEcCtD
Alfuzosin—Hyperhidrosis—Prednisolone—psoriasis	0.000472	0.000879	CcSEcCtD
Alfuzosin—Nausea—Hydroxyurea—psoriasis	0.00047	0.000876	CcSEcCtD
Alfuzosin—Pruritus—Mycophenolic acid—psoriasis	0.000469	0.000874	CcSEcCtD
Alfuzosin—Shock—Hydrocortisone—psoriasis	0.000469	0.000873	CcSEcCtD
Alfuzosin—Nervous system disorder—Hydrocortisone—psoriasis	0.000468	0.000871	CcSEcCtD
Alfuzosin—Eye disorder—Prednisone—psoriasis	0.000467	0.000869	CcSEcCtD
Alfuzosin—Tachycardia—Hydrocortisone—psoriasis	0.000465	0.000866	CcSEcCtD
Alfuzosin—Somnolence—Mycophenolate mofetil—psoriasis	0.000465	0.000866	CcSEcCtD
Alfuzosin—Drowsiness—Methotrexate—psoriasis	0.000465	0.000865	CcSEcCtD
Alfuzosin—Infestation NOS—Methotrexate—psoriasis	0.000465	0.000865	CcSEcCtD
Alfuzosin—Infestation—Methotrexate—psoriasis	0.000465	0.000865	CcSEcCtD
Alfuzosin—Flushing—Prednisone—psoriasis	0.000463	0.000863	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000463	0.000862	CcSEcCtD
Alfuzosin—Skin disorder—Hydrocortisone—psoriasis	0.000463	0.000862	CcSEcCtD
Alfuzosin—Ill-defined disorder—Dexamethasone—psoriasis	0.000463	0.000862	CcSEcCtD
Alfuzosin—Ill-defined disorder—Betamethasone—psoriasis	0.000463	0.000862	CcSEcCtD
Alfuzosin—Discomfort—Triamcinolone—psoriasis	0.000463	0.000861	CcSEcCtD
Alfuzosin—Fatigue—Cyclosporine—psoriasis	0.000463	0.000861	CcSEcCtD
Alfuzosin—Hyperhidrosis—Hydrocortisone—psoriasis	0.000461	0.000858	CcSEcCtD
Alfuzosin—Dyspepsia—Mycophenolate mofetil—psoriasis	0.000461	0.000858	CcSEcCtD
Alfuzosin—Constipation—Cyclosporine—psoriasis	0.000459	0.000854	CcSEcCtD
Alfuzosin—Pain—Cyclosporine—psoriasis	0.000459	0.000854	CcSEcCtD
Alfuzosin—Dry mouth—Triamcinolone—psoriasis	0.000458	0.000853	CcSEcCtD
Alfuzosin—Angioedema—Dexamethasone—psoriasis	0.000456	0.000849	CcSEcCtD
Alfuzosin—Angioedema—Betamethasone—psoriasis	0.000456	0.000849	CcSEcCtD
Alfuzosin—Diarrhoea—Mycophenolic acid—psoriasis	0.000454	0.000845	CcSEcCtD
Alfuzosin—Angiopathy—Prednisone—psoriasis	0.000453	0.000843	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000452	0.000841	CcSEcCtD
Alfuzosin—Malaise—Betamethasone—psoriasis	0.00045	0.000838	CcSEcCtD
Alfuzosin—Malaise—Dexamethasone—psoriasis	0.00045	0.000838	CcSEcCtD
Alfuzosin—Oedema—Triamcinolone—psoriasis	0.000449	0.000836	CcSEcCtD
Alfuzosin—Vertigo—Dexamethasone—psoriasis	0.000448	0.000835	CcSEcCtD
Alfuzosin—Vertigo—Betamethasone—psoriasis	0.000448	0.000835	CcSEcCtD
Alfuzosin—Syncope—Dexamethasone—psoriasis	0.000448	0.000833	CcSEcCtD
Alfuzosin—Syncope—Betamethasone—psoriasis	0.000448	0.000833	CcSEcCtD
Alfuzosin—Pain—Mycophenolate mofetil—psoriasis	0.000448	0.000833	CcSEcCtD
Alfuzosin—Constipation—Mycophenolate mofetil—psoriasis	0.000448	0.000833	CcSEcCtD
Alfuzosin—Infection—Triamcinolone—psoriasis	0.000446	0.00083	CcSEcCtD
Alfuzosin—Sweating—Methotrexate—psoriasis	0.000446	0.00083	CcSEcCtD
Alfuzosin—Hypotension—Hydrocortisone—psoriasis	0.000446	0.000829	CcSEcCtD
Alfuzosin—Feeling abnormal—Cyclosporine—psoriasis	0.000442	0.000823	CcSEcCtD
Alfuzosin—Shock—Triamcinolone—psoriasis	0.000442	0.000822	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Methotrexate—psoriasis	0.00044	0.000819	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Cyclosporine—psoriasis	0.000439	0.000817	CcSEcCtD
Alfuzosin—Loss of consciousness—Betamethasone—psoriasis	0.000439	0.000817	CcSEcCtD
Alfuzosin—Loss of consciousness—Dexamethasone—psoriasis	0.000439	0.000817	CcSEcCtD
Alfuzosin—Dizziness—Mycophenolic acid—psoriasis	0.000439	0.000816	CcSEcCtD
Alfuzosin—Tachycardia—Triamcinolone—psoriasis	0.000438	0.000816	CcSEcCtD
Alfuzosin—Mental disorder—Prednisone—psoriasis	0.000437	0.000814	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000434	0.000809	CcSEcCtD
Alfuzosin—Hyperhidrosis—Triamcinolone—psoriasis	0.000434	0.000808	CcSEcCtD
Alfuzosin—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000431	0.000803	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000428	0.000797	CcSEcCtD
Alfuzosin—Urticaria—Cyclosporine—psoriasis	0.000426	0.000794	CcSEcCtD
Alfuzosin—Abdominal pain—Cyclosporine—psoriasis	0.000424	0.00079	CcSEcCtD
Alfuzosin—Vomiting—Mycophenolic acid—psoriasis	0.000422	0.000785	CcSEcCtD
Alfuzosin—Discomfort—Dexamethasone—psoriasis	0.00042	0.000782	CcSEcCtD
Alfuzosin—Discomfort—Betamethasone—psoriasis	0.00042	0.000782	CcSEcCtD
Alfuzosin—Dyspepsia—Hydrocortisone—psoriasis	0.00042	0.000781	CcSEcCtD
Alfuzosin—Rash—Mycophenolic acid—psoriasis	0.000418	0.000778	CcSEcCtD
Alfuzosin—Dermatitis—Mycophenolic acid—psoriasis	0.000418	0.000778	CcSEcCtD
Alfuzosin—Pain—Prednisolone—psoriasis	0.000417	0.000777	CcSEcCtD
Alfuzosin—Urticaria—Mycophenolate mofetil—psoriasis	0.000416	0.000774	CcSEcCtD
Alfuzosin—Headache—Mycophenolic acid—psoriasis	0.000415	0.000773	CcSEcCtD
Alfuzosin—Pharyngitis—Methotrexate—psoriasis	0.000414	0.000771	CcSEcCtD
Alfuzosin—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000414	0.00077	CcSEcCtD
Alfuzosin—Urinary tract disorder—Methotrexate—psoriasis	0.000412	0.000767	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000412	0.000766	CcSEcCtD
Alfuzosin—Fatigue—Hydrocortisone—psoriasis	0.000411	0.000765	CcSEcCtD
Alfuzosin—Urethral disorder—Methotrexate—psoriasis	0.000409	0.000762	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000409	0.000762	CcSEcCtD
Alfuzosin—Pain—Hydrocortisone—psoriasis	0.000408	0.000759	CcSEcCtD
Alfuzosin—Oedema—Dexamethasone—psoriasis	0.000407	0.000758	CcSEcCtD
Alfuzosin—Oedema—Betamethasone—psoriasis	0.000407	0.000758	CcSEcCtD
Alfuzosin—Infection—Dexamethasone—psoriasis	0.000405	0.000753	CcSEcCtD
Alfuzosin—Infection—Betamethasone—psoriasis	0.000405	0.000753	CcSEcCtD
Alfuzosin—Ill-defined disorder—Prednisone—psoriasis	0.000403	0.000751	CcSEcCtD
Alfuzosin—Feeling abnormal—Prednisolone—psoriasis	0.000402	0.000749	CcSEcCtD
Alfuzosin—Shock—Dexamethasone—psoriasis	0.000401	0.000746	CcSEcCtD
Alfuzosin—Shock—Betamethasone—psoriasis	0.000401	0.000746	CcSEcCtD
Alfuzosin—Nervous system disorder—Dexamethasone—psoriasis	0.000399	0.000744	CcSEcCtD
Alfuzosin—Nervous system disorder—Betamethasone—psoriasis	0.000399	0.000744	CcSEcCtD
Alfuzosin—Thrombocytopenia—Betamethasone—psoriasis	0.000399	0.000743	CcSEcCtD
Alfuzosin—Thrombocytopenia—Dexamethasone—psoriasis	0.000399	0.000743	CcSEcCtD
Alfuzosin—Tachycardia—Dexamethasone—psoriasis	0.000398	0.00074	CcSEcCtD
Alfuzosin—Tachycardia—Betamethasone—psoriasis	0.000398	0.00074	CcSEcCtD
Alfuzosin—Angioedema—Prednisone—psoriasis	0.000397	0.000739	CcSEcCtD
Alfuzosin—Dyspepsia—Triamcinolone—psoriasis	0.000395	0.000736	CcSEcCtD
Alfuzosin—Nausea—Mycophenolic acid—psoriasis	0.000394	0.000733	CcSEcCtD
Alfuzosin—Hyperhidrosis—Betamethasone—psoriasis	0.000394	0.000733	CcSEcCtD
Alfuzosin—Hyperhidrosis—Dexamethasone—psoriasis	0.000394	0.000733	CcSEcCtD
Alfuzosin—Feeling abnormal—Hydrocortisone—psoriasis	0.000393	0.000732	CcSEcCtD
Alfuzosin—Malaise—Prednisone—psoriasis	0.000392	0.00073	CcSEcCtD
Alfuzosin—Vertigo—Prednisone—psoriasis	0.000391	0.000727	CcSEcCtD
Alfuzosin—Eye disorder—Methotrexate—psoriasis	0.00039	0.000726	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Hydrocortisone—psoriasis	0.00039	0.000726	CcSEcCtD
Alfuzosin—Syncope—Prednisone—psoriasis	0.00039	0.000726	CcSEcCtD
Alfuzosin—Urticaria—Prednisolone—psoriasis	0.000388	0.000722	CcSEcCtD
Alfuzosin—Cardiac disorder—Methotrexate—psoriasis	0.000387	0.000721	CcSEcCtD
Alfuzosin—Fatigue—Triamcinolone—psoriasis	0.000387	0.000721	CcSEcCtD
Alfuzosin—Asthenia—Cyclosporine—psoriasis	0.000385	0.000717	CcSEcCtD
Alfuzosin—Pain—Triamcinolone—psoriasis	0.000384	0.000715	CcSEcCtD
Alfuzosin—Loss of consciousness—Prednisone—psoriasis	0.000382	0.000711	CcSEcCtD
Alfuzosin—Hypotension—Dexamethasone—psoriasis	0.000381	0.000709	CcSEcCtD
Alfuzosin—Hypotension—Betamethasone—psoriasis	0.000381	0.000709	CcSEcCtD
Alfuzosin—Pruritus—Cyclosporine—psoriasis	0.00038	0.000707	CcSEcCtD
Alfuzosin—Urticaria—Hydrocortisone—psoriasis	0.000379	0.000705	CcSEcCtD
Alfuzosin—Angiopathy—Methotrexate—psoriasis	0.000379	0.000705	CcSEcCtD
Alfuzosin—Abdominal pain—Hydrocortisone—psoriasis	0.000377	0.000702	CcSEcCtD
Alfuzosin—Mediastinal disorder—Methotrexate—psoriasis	0.000376	0.0007	CcSEcCtD
Alfuzosin—Asthenia—Mycophenolate mofetil—psoriasis	0.000375	0.000699	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000371	0.000691	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000371	0.000691	CcSEcCtD
Alfuzosin—Pruritus—Mycophenolate mofetil—psoriasis	0.00037	0.000689	CcSEcCtD
Alfuzosin—Arthralgia—Prednisone—psoriasis	0.00037	0.000689	CcSEcCtD
Alfuzosin—Feeling abnormal—Triamcinolone—psoriasis	0.00037	0.000689	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000367	0.000684	CcSEcCtD
Alfuzosin—Diarrhoea—Cyclosporine—psoriasis	0.000367	0.000683	CcSEcCtD
Alfuzosin—Discomfort—Prednisone—psoriasis	0.000366	0.000681	CcSEcCtD
Alfuzosin—Mental disorder—Methotrexate—psoriasis	0.000366	0.000681	CcSEcCtD
Alfuzosin—Dyspepsia—Dexamethasone—psoriasis	0.000359	0.000668	CcSEcCtD
Alfuzosin—Dyspepsia—Betamethasone—psoriasis	0.000359	0.000668	CcSEcCtD
Alfuzosin—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000358	0.000667	CcSEcCtD
Alfuzosin—Urticaria—Triamcinolone—psoriasis	0.000357	0.000664	CcSEcCtD
Alfuzosin—Dizziness—Cyclosporine—psoriasis	0.000355	0.000661	CcSEcCtD
Alfuzosin—Oedema—Prednisone—psoriasis	0.000355	0.00066	CcSEcCtD
Alfuzosin—Infection—Prednisone—psoriasis	0.000352	0.000656	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Betamethasone—psoriasis	0.000352	0.000655	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000352	0.000655	CcSEcCtD
Alfuzosin—Back pain—Methotrexate—psoriasis	0.000351	0.000654	CcSEcCtD
Alfuzosin—Fatigue—Betamethasone—psoriasis	0.000351	0.000654	CcSEcCtD
Alfuzosin—Fatigue—Dexamethasone—psoriasis	0.000351	0.000654	CcSEcCtD
Alfuzosin—Shock—Prednisone—psoriasis	0.000349	0.00065	CcSEcCtD
Alfuzosin—Pain—Betamethasone—psoriasis	0.000348	0.000649	CcSEcCtD
Alfuzosin—Pain—Dexamethasone—psoriasis	0.000348	0.000649	CcSEcCtD
Alfuzosin—Nervous system disorder—Prednisone—psoriasis	0.000348	0.000648	CcSEcCtD
Alfuzosin—Tachycardia—Prednisone—psoriasis	0.000346	0.000645	CcSEcCtD
Alfuzosin—Dizziness—Mycophenolate mofetil—psoriasis	0.000346	0.000644	CcSEcCtD
Alfuzosin—Skin disorder—Prednisone—psoriasis	0.000345	0.000642	CcSEcCtD
Alfuzosin—Hyperhidrosis—Prednisone—psoriasis	0.000343	0.000639	CcSEcCtD
Alfuzosin—Asthenia—Hydrocortisone—psoriasis	0.000342	0.000637	CcSEcCtD
Alfuzosin—Vomiting—Cyclosporine—psoriasis	0.000341	0.000635	CcSEcCtD
Alfuzosin—Rash—Cyclosporine—psoriasis	0.000338	0.00063	CcSEcCtD
Alfuzosin—Dermatitis—Cyclosporine—psoriasis	0.000338	0.000629	CcSEcCtD
Alfuzosin—Pruritus—Hydrocortisone—psoriasis	0.000337	0.000628	CcSEcCtD
Alfuzosin—Ill-defined disorder—Methotrexate—psoriasis	0.000337	0.000628	CcSEcCtD
Alfuzosin—Headache—Cyclosporine—psoriasis	0.000336	0.000626	CcSEcCtD
Alfuzosin—Feeling abnormal—Betamethasone—psoriasis	0.000336	0.000625	CcSEcCtD
Alfuzosin—Feeling abnormal—Dexamethasone—psoriasis	0.000336	0.000625	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Betamethasone—psoriasis	0.000333	0.00062	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Dexamethasone—psoriasis	0.000333	0.00062	CcSEcCtD
Alfuzosin—Vomiting—Mycophenolate mofetil—psoriasis	0.000333	0.00062	CcSEcCtD
Alfuzosin—Rash—Mycophenolate mofetil—psoriasis	0.00033	0.000614	CcSEcCtD
Alfuzosin—Dermatitis—Mycophenolate mofetil—psoriasis	0.00033	0.000614	CcSEcCtD
Alfuzosin—Headache—Mycophenolate mofetil—psoriasis	0.000328	0.00061	CcSEcCtD
Alfuzosin—Malaise—Methotrexate—psoriasis	0.000328	0.00061	CcSEcCtD
Alfuzosin—Vertigo—Methotrexate—psoriasis	0.000326	0.000608	CcSEcCtD
Alfuzosin—Diarrhoea—Hydrocortisone—psoriasis	0.000326	0.000607	CcSEcCtD
Alfuzosin—Urticaria—Dexamethasone—psoriasis	0.000324	0.000603	CcSEcCtD
Alfuzosin—Urticaria—Betamethasone—psoriasis	0.000324	0.000603	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Prednisone—psoriasis	0.000323	0.000602	CcSEcCtD
Alfuzosin—Dizziness—Prednisolone—psoriasis	0.000323	0.000601	CcSEcCtD
Alfuzosin—Asthenia—Triamcinolone—psoriasis	0.000322	0.0006	CcSEcCtD
Alfuzosin—Abdominal pain—Betamethasone—psoriasis	0.000322	0.0006	CcSEcCtD
Alfuzosin—Abdominal pain—Dexamethasone—psoriasis	0.000322	0.0006	CcSEcCtD
Alfuzosin—Nausea—Cyclosporine—psoriasis	0.000319	0.000593	CcSEcCtD
Alfuzosin—Pruritus—Triamcinolone—psoriasis	0.000318	0.000591	CcSEcCtD
Alfuzosin—Dizziness—Hydrocortisone—psoriasis	0.000315	0.000587	CcSEcCtD
Alfuzosin—Dyspepsia—Prednisone—psoriasis	0.000312	0.000581	CcSEcCtD
Alfuzosin—Nausea—Mycophenolate mofetil—psoriasis	0.000311	0.000579	CcSEcCtD
Alfuzosin—Arthralgia—Methotrexate—psoriasis	0.000309	0.000576	CcSEcCtD
Alfuzosin—Chest pain—Methotrexate—psoriasis	0.000309	0.000576	CcSEcCtD
Alfuzosin—Rash—Prednisolone—psoriasis	0.000308	0.000573	CcSEcCtD
Alfuzosin—Dermatitis—Prednisolone—psoriasis	0.000308	0.000573	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.000307	0.000572	CcSEcCtD
Alfuzosin—Fatigue—Prednisone—psoriasis	0.000306	0.000569	CcSEcCtD
Alfuzosin—Headache—Prednisolone—psoriasis	0.000306	0.000569	CcSEcCtD
Alfuzosin—Discomfort—Methotrexate—psoriasis	0.000306	0.000569	CcSEcCtD
Alfuzosin—Constipation—Prednisone—psoriasis	0.000303	0.000565	CcSEcCtD
Alfuzosin—Vomiting—Hydrocortisone—psoriasis	0.000303	0.000564	CcSEcCtD
Alfuzosin—Rash—Hydrocortisone—psoriasis	0.000301	0.00056	CcSEcCtD
Alfuzosin—Dermatitis—Hydrocortisone—psoriasis	0.0003	0.000559	CcSEcCtD
Alfuzosin—Headache—Hydrocortisone—psoriasis	0.000299	0.000556	CcSEcCtD
Alfuzosin—Dizziness—Triamcinolone—psoriasis	0.000297	0.000553	CcSEcCtD
Alfuzosin—Infection—Methotrexate—psoriasis	0.000295	0.000548	CcSEcCtD
Alfuzosin—Feeling abnormal—Prednisone—psoriasis	0.000292	0.000544	CcSEcCtD
Alfuzosin—Asthenia—Dexamethasone—psoriasis	0.000292	0.000544	CcSEcCtD
Alfuzosin—Asthenia—Betamethasone—psoriasis	0.000292	0.000544	CcSEcCtD
Alfuzosin—Nervous system disorder—Methotrexate—psoriasis	0.000291	0.000541	CcSEcCtD
Alfuzosin—Thrombocytopenia—Methotrexate—psoriasis	0.00029	0.00054	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Prednisone—psoriasis	0.00029	0.00054	CcSEcCtD
Alfuzosin—Nausea—Prednisolone—psoriasis	0.00029	0.00054	CcSEcCtD
Alfuzosin—Pruritus—Betamethasone—psoriasis	0.000288	0.000537	CcSEcCtD
Alfuzosin—Pruritus—Dexamethasone—psoriasis	0.000288	0.000537	CcSEcCtD
Alfuzosin—Skin disorder—Methotrexate—psoriasis	0.000288	0.000536	CcSEcCtD
Alfuzosin—Hyperhidrosis—Methotrexate—psoriasis	0.000287	0.000534	CcSEcCtD
Alfuzosin—Vomiting—Triamcinolone—psoriasis	0.000285	0.000531	CcSEcCtD
Alfuzosin—Nausea—Hydrocortisone—psoriasis	0.000283	0.000527	CcSEcCtD
Alfuzosin—Rash—Triamcinolone—psoriasis	0.000283	0.000527	CcSEcCtD
Alfuzosin—Dermatitis—Triamcinolone—psoriasis	0.000283	0.000527	CcSEcCtD
Alfuzosin—Urticaria—Prednisone—psoriasis	0.000282	0.000525	CcSEcCtD
Alfuzosin—Headache—Triamcinolone—psoriasis	0.000281	0.000524	CcSEcCtD
Alfuzosin—Abdominal pain—Prednisone—psoriasis	0.00028	0.000522	CcSEcCtD
Alfuzosin—Diarrhoea—Dexamethasone—psoriasis	0.000279	0.000519	CcSEcCtD
Alfuzosin—Diarrhoea—Betamethasone—psoriasis	0.000279	0.000519	CcSEcCtD
Alfuzosin—Hypotension—Methotrexate—psoriasis	0.000277	0.000516	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Methotrexate—psoriasis	0.00027	0.000503	CcSEcCtD
Alfuzosin—Dizziness—Dexamethasone—psoriasis	0.000269	0.000502	CcSEcCtD
Alfuzosin—Dizziness—Betamethasone—psoriasis	0.000269	0.000502	CcSEcCtD
Alfuzosin—Nausea—Triamcinolone—psoriasis	0.000267	0.000496	CcSEcCtD
Alfuzosin—Somnolence—Methotrexate—psoriasis	0.000264	0.000491	CcSEcCtD
Alfuzosin—Dyspepsia—Methotrexate—psoriasis	0.000261	0.000486	CcSEcCtD
Alfuzosin—Vomiting—Betamethasone—psoriasis	0.000259	0.000482	CcSEcCtD
Alfuzosin—Vomiting—Dexamethasone—psoriasis	0.000259	0.000482	CcSEcCtD
Alfuzosin—Rash—Betamethasone—psoriasis	0.000257	0.000478	CcSEcCtD
Alfuzosin—Rash—Dexamethasone—psoriasis	0.000257	0.000478	CcSEcCtD
Alfuzosin—Dermatitis—Dexamethasone—psoriasis	0.000257	0.000478	CcSEcCtD
Alfuzosin—Dermatitis—Betamethasone—psoriasis	0.000257	0.000478	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Methotrexate—psoriasis	0.000256	0.000477	CcSEcCtD
Alfuzosin—Fatigue—Methotrexate—psoriasis	0.000256	0.000476	CcSEcCtD
Alfuzosin—Headache—Betamethasone—psoriasis	0.000255	0.000475	CcSEcCtD
Alfuzosin—Headache—Dexamethasone—psoriasis	0.000255	0.000475	CcSEcCtD
Alfuzosin—Asthenia—Prednisone—psoriasis	0.000255	0.000474	CcSEcCtD
Alfuzosin—Pain—Methotrexate—psoriasis	0.000254	0.000472	CcSEcCtD
Alfuzosin—Pruritus—Prednisone—psoriasis	0.000251	0.000467	CcSEcCtD
Alfuzosin—Feeling abnormal—Methotrexate—psoriasis	0.000244	0.000455	CcSEcCtD
Alfuzosin—Diarrhoea—Prednisone—psoriasis	0.000243	0.000452	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Methotrexate—psoriasis	0.000242	0.000451	CcSEcCtD
Alfuzosin—Nausea—Dexamethasone—psoriasis	0.000242	0.00045	CcSEcCtD
Alfuzosin—Nausea—Betamethasone—psoriasis	0.000242	0.00045	CcSEcCtD
Alfuzosin—Urticaria—Methotrexate—psoriasis	0.000236	0.000439	CcSEcCtD
Alfuzosin—Dizziness—Prednisone—psoriasis	0.000235	0.000437	CcSEcCtD
Alfuzosin—Abdominal pain—Methotrexate—psoriasis	0.000234	0.000436	CcSEcCtD
Alfuzosin—Vomiting—Prednisone—psoriasis	0.000226	0.00042	CcSEcCtD
Alfuzosin—Rash—Prednisone—psoriasis	0.000224	0.000416	CcSEcCtD
Alfuzosin—Dermatitis—Prednisone—psoriasis	0.000223	0.000416	CcSEcCtD
Alfuzosin—Headache—Prednisone—psoriasis	0.000222	0.000414	CcSEcCtD
Alfuzosin—Asthenia—Methotrexate—psoriasis	0.000213	0.000396	CcSEcCtD
Alfuzosin—Nausea—Prednisone—psoriasis	0.000211	0.000392	CcSEcCtD
Alfuzosin—Pruritus—Methotrexate—psoriasis	0.00021	0.000391	CcSEcCtD
Alfuzosin—Diarrhoea—Methotrexate—psoriasis	0.000203	0.000378	CcSEcCtD
Alfuzosin—Dizziness—Methotrexate—psoriasis	0.000196	0.000365	CcSEcCtD
Alfuzosin—Vomiting—Methotrexate—psoriasis	0.000188	0.000351	CcSEcCtD
Alfuzosin—Rash—Methotrexate—psoriasis	0.000187	0.000348	CcSEcCtD
Alfuzosin—Dermatitis—Methotrexate—psoriasis	0.000187	0.000348	CcSEcCtD
Alfuzosin—Headache—Methotrexate—psoriasis	0.000186	0.000346	CcSEcCtD
Alfuzosin—Nausea—Methotrexate—psoriasis	0.000176	0.000328	CcSEcCtD
